Nowadays, the COVID-19 epidemic causes stress not only to healthy people but also to people with unhealthy conditions. Excess psychological stress (either in quality, quantity, frequency, and/or duration) could push susceptible individuals to ultimately develop clinical asthma. Depression was significantly associated with asthma interference with daily activities, breathlessness, night symptoms, use of bronchodilators, and poor compliance with medical treatment. Covid-19 pandemic induced the countries around the world to require from its citizens not to ask for health care support rather than in emergency situations and through utilizing telemedicine. This action aims to control spreading the infection with viruses as well as to reduce the workload on the healthcare providers. Although asthma is not listed as one of the chronic conditions that might complicate coronavirus infections, asthma people might have a high-stress level that might induce their asthma attack which consequentially reflects on their quality of life. People with asthma have a unique experience rather than people with other health conditions during COVID-19. Patients with asthma experience a lot of stressors that might induce asthma and impaired their HRQOL such as overuse of antiseptic substances, stay home with a sedentary lifestyle, the sudden shift to telemedicine, and electronic work from home. Also, as a result of the similarity of asthma symptoms with coronavirus symptoms, the patient might have a continuous sense of uncertainty that s/he is infected with the COVID-19 virus, and this suspicion can increase the psychological overburden on these patients. Therefore, all these stressors should be evaluated to recognize their health needs and the kind of social and health support that should be provided to them during the pandemic time. Also, Identifying the predictors of HRQOL among patients with asthma during the pandemic of COVID-19 is urgently required.
Asthma is a chronic inflammatory disease of the lower respiratory tract which derives from a
combination of genetic predisposition with environmental exposure to several factors. It is a
chronic respiratory disease that results in morbidity, mortality, and impaired health-related
quality of life (HRQoL). It is estimated that 334 million people have asthma worldwide.
Nowadays, the COVID-19 epidemic causes stress not only to healthy people but also to people
with unhealthy conditions. Excess psychological stress (either in quality, quantity,
frequency, and/or duration) could push susceptible individuals to ultimately develop clinical
asthma. Depression was significantly associated with asthma interference with daily
activities, breathlessness, night symptoms, use of bronchodilators, and poor compliance with
medical treatment.
Covid-19 pandemic induced the countries around the world to require from its citizens not to
ask for health care support rather than in emergency situations and through utilizing
telemedicine. This action aims to control spreading the infection with viruses as well as to
reduce the workload on the healthcare providers.
Although asthma is not listed as one of the chronic conditions that might complicate
coronavirus infections, asthma people might have a high-stress level that might induce their
asthma attack which consequentially reflects on their quality of life. People with asthma
have a unique experience rather than people with other health conditions during COVID-19.
Patients with asthma experience a lot of stressors that might induce asthma and impaired
their HRQOL such as overuse of antiseptic substances, stay home with a sedentary lifestyle,
the sudden shift to telemedicine, and electronic work from home. Also, as a result of the
similarity of asthma symptoms with coronavirus symptoms, the patient might have a continuous
sense of uncertainty that s/he is infected with the COVID-19 virus, and this suspicion can
increase the psychological overburden on these patients.
Therefore, all these stressors should be evaluated to recognize their health needs and the
kind of social and health support that should be provided to them during the pandemic time.
Also, Identifying the predictors of HRQOL among patients with asthma during the pandemic of
COVID-19 is urgently required.
A cross-sectional analytical design will be utilized.
The study participants will be adults (18 years or older) who have been diagnosed with
bronchial asthma or pulmonary disease.
Inclusion Criteria:
- Participant's age: 18 years or older
- medically diagnosed with bronchial asthma
Exclusion Criteria:
- not medically diagnosed with asthma by a physician
Egypt
Cairo, Egypt
Investigator: Youssef
Contact: +201149495552
youssef_naglaa@cu.edu.eg
Youssef
+201149495552
youssef_naglaa@cu.edu.eg
Naglaa Youssef, Principal Investigator
Cairo University